CD8+CD45RA+CCR7+FOXP3+ T Cells with Immunosuppressive Properties: a Novel Subset of Inducible Human Regulatory T Cells
Overview
Authors
Affiliations
CD8 T cells stimulated with a suboptimal dose of anti-CD3 Abs (100 pg/ml) in the presence of IL-15 retain a naive phenotype with expression of CD45RA, CD28, CD27, and CCR7 but acquire new functions and differentiate into immunosuppressive T cells. CD8+CCR7+ regulatory T cells (Tregs) express FOXP3 and prevent CD4 T cells from responding to TCR stimulation and entering the cell cycle. Naive CD4 T cells are more susceptible to inhibition than memory cells. The suppressive activity of CD8+CCR7+ Tregs is not mediated by IL-10, TGF-β, CTLA-4, CCL4, or adenosine and relies on interference with very early steps of the TCR signaling cascade. Specifically, CD8+CCR7+ Tregs prevent TCR-induced phosphorylation of ZAP70 and dampen the rise of intracellular calcium in CD4 T cells. The inducibility of CD8+CCR7+ Tregs is correlated with the age of the individual with PBLs of donors older than 60 y yielding low numbers of FOXP3(low) CD8 Tregs. Loss of CD8+CCR7+ Tregs in the elderly host may be of relevance in the aging immune system as immunosenescence is associated with a state of chronic smoldering inflammation.
CD8 Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis.
Watanabe R, Kadoba K, Tamamoto A, Murata K, Murakami K, Onizawa H J Clin Med. 2023; 12(6).
PMID: 36983342 PMC: 10054757. DOI: 10.3390/jcm12062342.
Impact of Manufacturing Procedures on CAR T Cell Functionality.
Watanabe N, Mo F, McKenna M Front Immunol. 2022; 13:876339.
PMID: 35493513 PMC: 9043864. DOI: 10.3389/fimmu.2022.876339.
Regulatory T Cells in Autoimmune Vasculitis.
Jin K, Parreau S, Warrington K, Koster M, Berry G, Goronzy J Front Immunol. 2022; 13:844300.
PMID: 35296082 PMC: 8918523. DOI: 10.3389/fimmu.2022.844300.
Perdaens O, van Pesch V Front Neurol. 2022; 12:811518.
PMID: 35281989 PMC: 8913495. DOI: 10.3389/fneur.2021.811518.
Age as a risk factor in vasculitis.
Gloor A, Berry G, Goronzy J, Weyand C Semin Immunopathol. 2022; 44(3):281-301.
PMID: 35141865 PMC: 9064861. DOI: 10.1007/s00281-022-00911-1.